| T22984 |
MJ 15
|
944154-76-1
|
98%
|
|
|
MJ 15 is a CB1 receptor antagonist with specificity for the study of obesity-induced diseases.
|
| T14011 |
2-Arachidonoylglycerol
|
53847-30-6
|
98%
|
|
|
In the central nervous system, 2-Arachidonoylglycerol is a second endogenous cannabinoid ligand
|
| T1519 |
Rimonabant hydrochloride
|
158681-13-1
|
98%
|
|
|
Rimonabant hydrochloride (SR 141716A) is a cannabinoid receptor antagonist, binding selectively to central cannabinoid receptors (CB1) with high affinity.
|
| T64394 |
GW 833972A
|
1092502-33-4
|
98%
|
|
|
GW 833972A is a selective CB2 receptor agonist.GW 833972A has an inhibitory effect on induced neural depolarization and on citric acid-induced cough in an animal...
|
| T61562 |
CB1R Allosteric modulator 3
|
2633686-36-7
|
98%
|
|
|
CB1R Allosteric modulator 3 is a potent CB1R modulator.CB1R Allosteric modulator 3 inhibits cAMP and β-Arrestin, and can be used for the study of obesity and nic...
|
| T62761 |
CB1 agonist 1
|
851212-80-1
|
98%
|
|
|
CB1 agonist 1 is a potent CB1 agonist with a pIC50 value of 5.7 for CB1 receptors.CB1 agonist 1 can be used to study brain disorders, pain, and inflammation.
|
| T79909 |
AEF0117
|
1610878-71-1
|
98%
|
|
|
AEF0117, a signaling-specific inhibitor of cannabinoid receptor 1 (CB1-SSi), inhibits cannabinoid self-administration and behavioral disorders associated with TH...
|
| T61989 |
CB1R antagonist 1
|
334668-69-8
|
98%
|
|
|
CB1R antagonist 1 is a potent CB1R antagonist that can be used to study diseases related to the nervous system.
|
| T19705 |
JTE-907
|
282089-49-0
|
100%
|
|
|
JTE-907 is a CB2 receptor inverse agonist with high selectivity and oral activity.JTE-907 exhibits anti-inflammatory activity in vivo.
|
| T0851 |
Pregnenolone
|
145-13-1
|
100%
|
|
|
Pregnenolone (Arthenolone) is an endogenous steroid hormone synthesized from cholesterol, used in the treatment of Alzheimer's disease.
|
| T67896 |
CB2R/FAAH modulator-1
|
928892-60-8
|
100%
|
|
|
CB2R/FAAH modulator-1, a cannabinoid type 2 receptor (CB2R) agonist, is also a fatty acid amide hydrolase (FAAH) inhibitor (IC50=4 μM) that reduces the productio...
|
| TN2268 |
Tetrahydromagnolol
|
20601-85-8
|
100%
|
|
|
Tetrahydromagnolol can activate cannabinoid (CB) receptors.
|
| T3530 |
Otenabant
|
686344-29-6
|
100%
|
|
|
Otenabant (CP-945598) has been investigated for the treatment of Obesity.
|
| T8511 |
TM38837
|
1253641-65-4
|
100%
|
|
|
TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.
|
| T24771 |
SCH-336
|
447459-51-0
|
95.01%
|
|
|
SCH-336 is a CB2 receptor agonist (Ki-1.8 nM, EC50-2 nM) with effective, selective, and oral activity. SCH-336 is also bioactive against CB1 receptor, and is 100...
|
| TN5131 |
Tetrahydrocannabivarin
|
31262-37-0
|
96.30%
|
|
|
Tetrahydrocannabivarin (CRM) is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimu...
|
| T14302 |
Olorinab
|
1268881-20-4
|
97.13%
|
|
|
Olorinab (APD 371) (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist. With an EC50 of 6.2 nM for hCB2.
|
| T9114 |
β-Caryophyllene
|
87-44-5
|
97.31%
|
|
|
β-Caryophyllene ((-)-(E)-Caryophyllene) acts as an CB2 receptor agonist.
|
| T1915 |
AM251
|
183232-66-8
|
97.88%
|
|
|
AM251 is a effective CB1 receptor antagonist (IC50/Ki: 8 /7.49 nM) that displays 306-fold selectivity over CB2 receptors; also effective GPR55 agonist (EC50: 39 ...
|
| T3S0738 |
Yangonin
|
500-62-9
|
98%
|
|
|
Yangonin (Y100550) is a novel CB receptor ligand, it exhibits affinity for the human recombinant CB receptor. Yangonin (Y100550) could be a valuable candidate fo...
|
